SpectraScience, a San Diego based medical device company, has received a European patent for its Optical Biopsy System for tissue diagnosis.
Subscribe to our email newsletter
Jim Hitchin, SpectraScience’s CEO, said: “This patent is important to the company’s optical biopsy technology because it provides protection in the areas of tissue surveillance, characterization, diagnosis and treatment. It supports the company’s fundamental technology of non-invasive, low-level laser diagnosis of pre-cancerous and cancerous tissue.
“This is another key patent in our intellectual property portfolio that underscores our commitment at SpectraScience to develop better, more reliable cancer screening technologies.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.